Assuming CCE's inaccuracies in diagnosing CML and FISH's limitations with low BCR‐ABL1 percentages, a Predicted‐FISH (Pred‐FISH) was developed. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.